1.
Cancer Med
; 12(2): 1869-1877, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35796421
RESUMO
Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing and retaining minority patients into clinical trials. This study sought to identify and address barriers to minority accrual to a minimal risk clinical research study in real-time.